{"id":"https://openalex.org/W4212939704","doi":"https://doi.org/10.1200/jco.2022.40.6_suppl.506","title":"NEXT: A single-arm, phase 2, open-label study of adjuvant nivolumab after completion of chemo-radiation therapy in patients with localized muscle-invasive bladder cancer.","display_name":"NEXT: A single-arm, phase 2, open-label study of adjuvant nivolumab after completion of chemo-radiation therapy in patients with localized muscle-invasive bladder cancer.","publication_year":2022,"publication_date":"2022-02-16","ids":{"openalex":"https://openalex.org/W4212939704","doi":"https://doi.org/10.1200/jco.2022.40.6_suppl.506"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2022.40.6_suppl.506","doi":"https://doi.org/10.1200/jco.2022.40.6_suppl.506","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.6_suppl.506","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5013942253","display_name":"Sumati V. Gupta","orcid":"https://orcid.org/0000-0001-6271-0831","observed_orcids":["https://orcid.org/0000-0001-6271-0831"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]},{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sumati Gupta","raw_affiliation_strings":["Huntsman Cancer Institute, University of Utah, Salt Lake City, UT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huntsman Cancer Institute, University of Utah, Salt Lake City, UT;","institution_ids":["https://openalex.org/I223532165","https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059162411","display_name":"George Daniel Grass","orcid":"https://orcid.org/0000-0002-8417-5611","observed_orcids":["https://orcid.org/0000-0002-8417-5611"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G. Daniel Grass","raw_affiliation_strings":["H. Lee Moffitt Cancer Center, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022744341","display_name":"Benjamin Louis Maughan","orcid":"https://orcid.org/0000-0002-0010-8551","observed_orcids":["https://orcid.org/0000-0002-0010-8551"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]},{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Benjamin L. Maughan","raw_affiliation_strings":["Huntsman Cancer Institute, University of Utah, Salt Lake City, UT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huntsman Cancer Institute, University of Utah, Salt Lake City, UT;","institution_ids":["https://openalex.org/I223532165","https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023152191","display_name":"Rohit Jain","orcid":"https://orcid.org/0000-0002-9295-9360","observed_orcids":["https://orcid.org/0000-0002-9295-9360"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rohit K. Jain","raw_affiliation_strings":["H. Lee Moffitt Cancer Center, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090253469","display_name":"Christopher Dechet","orcid":"https://orcid.org/0000-0002-0534-6006","observed_orcids":["https://orcid.org/0000-0002-0534-6006"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]},{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher B. Dechet","raw_affiliation_strings":["Huntsman Cancer Institute, University of Utah, Salt Lake City, UT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huntsman Cancer Institute, University of Utah, Salt Lake City, UT;","institution_ids":["https://openalex.org/I223532165","https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063526218","display_name":"Alejandro S\u00e1nchez","orcid":"https://orcid.org/0000-0002-9054-7346","observed_orcids":["https://orcid.org/0000-0002-9054-7346"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]},{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alejandro Sanchez","raw_affiliation_strings":["Huntsman Cancer Institute, University of Utah, Salt Lake City, UT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huntsman Cancer Institute, University of Utah, Salt Lake City, UT;","institution_ids":["https://openalex.org/I223532165","https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110579727","display_name":"Brock O Neil","orcid":"https://orcid.org/0000-0002-1497-5824","observed_orcids":["https://orcid.org/0000-0002-1497-5824"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]},{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brock O Neil","raw_affiliation_strings":["Huntsman Cancer Institute, University of Utah, Salt Lake City, UT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huntsman Cancer Institute, University of Utah, Salt Lake City, UT;","institution_ids":["https://openalex.org/I223532165","https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087611807","display_name":"Michael Adam Poch","orcid":"https://orcid.org/0000-0001-7339-8978","observed_orcids":["https://orcid.org/0000-0001-7339-8978"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Adam Poch","raw_affiliation_strings":["H. Lee Moffitt Cancer Center, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054735116","display_name":"Roger Li","orcid":"https://orcid.org/0000-0003-1274-7200","observed_orcids":["https://orcid.org/0000-0003-1274-7200"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Roger Li","raw_affiliation_strings":["H. Lee Moffitt Cancer Center, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057200744","display_name":"Shane A. J. Lloyd","orcid":"https://orcid.org/0000-0002-4235-7652","observed_orcids":["https://orcid.org/0000-0002-4235-7652"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]},{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shane Lloyd","raw_affiliation_strings":["Huntsman Cancer Institute, University of Utah, Salt Lake City, UT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huntsman Cancer Institute, University of Utah, Salt Lake City, UT;","institution_ids":["https://openalex.org/I223532165","https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040908498","display_name":"Jonathan David Tward","orcid":"https://orcid.org/0000-0001-7765-4473","observed_orcids":["https://orcid.org/0000-0001-7765-4473"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]},{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jonathan David Tward","raw_affiliation_strings":["Huntsman Cancer Institute, University of Utah, Salt Lake City, UT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huntsman Cancer Institute, University of Utah, Salt Lake City, UT;","institution_ids":["https://openalex.org/I223532165","https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070458204","display_name":"Tenzin Kunsang Phunrab","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]},{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tenzin Kunsang Phunrab","raw_affiliation_strings":["Huntsman Cancer Institute, University of Utah, Salt Lake City, UT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huntsman Cancer Institute, University of Utah, Salt Lake City, UT;","institution_ids":["https://openalex.org/I223532165","https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076648854","display_name":"Josiah Hawks","orcid":"https://orcid.org/0000-0001-9908-4598","observed_orcids":["https://orcid.org/0000-0001-9908-4598"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]},{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Josiah Hawks","raw_affiliation_strings":["Huntsman Cancer Institute, University of Utah, Salt Lake City, UT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huntsman Cancer Institute, University of Utah, Salt Lake City, UT;","institution_ids":["https://openalex.org/I223532165","https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034103357","display_name":"Umang Swami","orcid":"https://orcid.org/0000-0003-3518-0411","observed_orcids":["https://orcid.org/0000-0003-3518-0411"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]},{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Umang Swami","raw_affiliation_strings":["Huntsman Cancer Institute, University of Utah, Salt Lake City, UT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huntsman Cancer Institute, University of Utah, Salt Lake City, UT;","institution_ids":["https://openalex.org/I223532165","https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082070319","display_name":"Kenneth M. Boucher","orcid":"https://orcid.org/0000-0003-2833-0127","observed_orcids":["https://orcid.org/0000-0003-2833-0127"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]},{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth M Boucher","raw_affiliation_strings":["Huntsman Cancer Institute, University of Utah, Salt Lake City, UT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huntsman Cancer Institute, University of Utah, Salt Lake City, UT;","institution_ids":["https://openalex.org/I223532165","https://openalex.org/I2801159745"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100763587","display_name":"Neeraj Agarwal","orcid":"https://orcid.org/0000-0003-1076-0428","observed_orcids":["https://orcid.org/0000-0003-1076-0428","https://orcid.org/0000-0001-6574-8499"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]},{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neeraj Agarwal","raw_affiliation_strings":["Huntsman Cancer Institute, University of Utah, Salt Lake City, UT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huntsman Cancer Institute, University of Utah, Salt Lake City, UT;","institution_ids":["https://openalex.org/I223532165","https://openalex.org/I2801159745"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"40","issue":"6_suppl","first_page":"506","last_page":"506"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12695","display_name":"Urinary and Genital Oncology Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.9039999842643738},{"id":"https://openalex.org/keywords/adjuvant-immunotherapy","display_name":"adjuvant immunotherapy","score":0.9120000004768372},{"id":"https://openalex.org/keywords/muscle-invasive-bladder-cancer","display_name":"muscle-invasive bladder cancer","score":0.9110000133514404},{"id":"https://openalex.org/keywords/chemoradiotherapy","display_name":"chemoradiotherapy","score":0.8360000252723694},{"id":"https://openalex.org/keywords/failure-free-survival","display_name":"failure-free survival","score":0.8529999852180481},{"id":"https://openalex.org/keywords/local-recurrence","display_name":"local recurrence","score":0.5830000042915344},{"id":"https://openalex.org/keywords/treatment-related-adverse-events","display_name":"treatment-related adverse events","score":0.7870000004768372},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.9800000190734863},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.6060000061988831},{"id":"https://openalex.org/keywords/localized-bladder-cancer","display_name":"localized bladder cancer","score":0.6809999942779541},{"id":"https://openalex.org/keywords/radical-cystectomy-alternative","display_name":"radical cystectomy alternative","score":0.5220000147819519},{"id":"https://openalex.org/keywords/rtog-toxicity-grading","display_name":"RTOG toxicity grading","score":0.5149999856948853},{"id":"https://openalex.org/keywords/pd-1-inhibitors","display_name":"PD-1 inhibitors","score":0.3799999952316284},{"id":"https://openalex.org/keywords/immunotherapy-safety-and-efficacy","display_name":"immunotherapy safety and efficacy","score":0.44999998807907104},{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.48100000619888306}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9599242806434631},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.7936966419219971},{"id":"https://openalex.org/C2775910329","wikidata":"https://www.wikidata.org/wiki/Q245995","display_name":"Cystectomy","level":4,"score":0.6901882886886597},{"id":"https://openalex.org/C61943457","wikidata":"https://www.wikidata.org/wiki/Q6046661","display_name":"Interim analysis","level":3,"score":0.6827656626701355},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.623451828956604},{"id":"https://openalex.org/C2780352672","wikidata":"https://www.wikidata.org/wiki/Q504775","display_name":"Bladder cancer","level":3,"score":0.5973113179206848},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.517127513885498},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.5068503022193909},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4992208480834961},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.44528359174728394},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4355001151561737},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.39623335003852844},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.33393561840057373},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3324422240257263},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.10189256072044373}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2022.40.6_suppl.506","doi":"https://doi.org/10.1200/jco.2022.40.6_suppl.506","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.6_suppl.506","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3007185425","https://openalex.org/W4391333767","https://openalex.org/W7171711609","https://openalex.org/W4408553793","https://openalex.org/W4402297697","https://openalex.org/W2794076680","https://openalex.org/W7131878263","https://openalex.org/W4391333814","https://openalex.org/W3166050845","https://openalex.org/W4289550758"],"abstract_inverted_index":{"506":[0],"Background:":[1],"Nivolumab":[2],"has":[3,204,333],"known":[4],"efficacy":[5,23,139],"as":[6,105],"adjuvant":[7,26,150,281,320,327],"therapy":[8,30,258],"after":[9],"radical":[10],"cystectomy":[11],"in":[12,32,206,217,245,264,272,286,303],"localized":[13,45,324],"muscle":[14],"invasive":[15],"bladder":[16,214,325],"cancer":[17],"(MIBC).":[18],"We":[19,121,132],"are":[20,40,51,76,243,269,284,299],"evaluating":[21],"the":[22,36,82,98,143,176,185,276,287,304,316],"of":[24,68,70,100,117,179,209,280,289,306,315,318],"nivolumab":[25,54,180,328],"to":[27,62,141,155,321],"definitive":[28],"chemo-radiation":[29],"(CRT)":[31],"MIBC.":[33],"Methods:":[34],"In":[35,311],"NEXT":[37],"study,":[38],"we":[39],"currently":[41],"enrolling":[42],"patients":[43,158,247,274],"with":[44,102,147],"MIBC":[46],"undergoing":[47],"standard":[48],"CRT.":[49,71],"Participants":[50],"started":[52],"on":[53,126],"480":[55],"mg":[56],"IV":[57],"every":[58,78],"4":[59,211],"weeks":[60],"(up":[61],"12":[63],"doses)":[64],"within":[65],"90":[66],"days":[67],"completion":[69],"Cystoscopic":[72],"and":[73,115,129,138,149,184,219,252,283,296,332],"scan-based":[74],"assessments":[75],"done":[77],"3":[79,256,278],"months":[80,230,234,279],"for":[81,275,323],"first":[83,277,313],"two":[84,162],"years":[85],"(yrs).":[86],"The":[87,191,224],"primary":[88],"endpoint":[89],"is":[90,166,172,182,188,196,228,329],"failure-free":[91],"survival":[92],"(FFS)":[93],"at":[94,161],"2":[95,265],"yrs":[96],"from":[97],"start":[99],"CRT,":[101],"failure":[103],"defined":[104],"local":[106,213],"or":[107],"systemic":[108],"disease":[109],"recurrence.":[110],"Secondary":[111],"endpoints":[112],"include":[113],"toxicity":[114],"quality":[116],"life":[118],"(QOL)":[119],"assessments.":[120],"have":[122,212,221],"planned":[123],"correlative":[124],"studies":[125],"peripheral":[127],"blood":[128],"tumor":[130],"tissue.":[131],"performed":[133],"a":[134],"protocol-defined":[135],"interim":[136],"safety":[137],"analysis":[140],"assess":[142],"6-month":[144,193],"FFS":[145,194,227],"rate":[146,195],"CRT":[148,322],"nivolumab.":[151],"Results:":[152],"From":[153],"8/03/2017":[154],"9/28/2021,":[156],"20":[157],"were":[159],"enrolled":[160],"centers;":[163],"median":[164,177,186,226],"age":[165],"76":[167],"yrs,":[168],"clinical":[169],"stage":[170],"range":[171],"T2-T4b,":[173],"N0-N+,":[174],"M0;":[175],"number":[178],"cycles":[181],"6.5,":[183],"follow-up":[187],"8.9":[189],"months.":[190],"estimated":[192,225],"88.2%":[197],"(95%":[198,231],"CI":[199,232],"74.2%":[200],"-":[201,235],"100%).":[202],"Disease":[203],"progressed":[205],"9":[207],"patients,":[208],"which":[210],"recurrence":[215],"(T1":[216],"3/4)":[218],"5":[220],"distant":[222],"metastases.":[223],"17.1":[229],"8.71":[233],"infinity).":[236],"Grade":[237,255],"\u22653":[238],"treatment-related":[239],"adverse":[240],"events":[241],"(AEs)":[242],"noted":[244],"3/20":[246],"(15%):":[248],"elevated":[249],"transaminases,":[250],"diarrhea,":[251],"polymyalgia":[253],"rheumatica.":[254],"radiation":[257],"oncology":[259],"group":[260],"(RTOG)":[261],"AEs":[262],"occurred":[263],"patients.":[266],"QOL":[267],"measures":[268],"serially":[270],"evaluable":[271],"13":[273],"nivolumab,":[282],"stable":[285],"domains":[288],"disease-related":[290,307],"physical":[291],"symptoms,":[292],"treatment":[293],"side":[294],"effects,":[295],"function/well-being,":[297],"while":[298],"significantly":[300],"improved":[301],"(p=0.023)":[302],"domain":[305],"emotional":[308],"symptoms.":[309],"Conclusions:":[310],"this":[312],"report":[314],"role":[317],"immunotherapy":[319],"cancer,":[326],"well":[330],"tolerated":[331],"promising":[334],"efficacy.":[335],"Clinical":[336],"trial":[337],"information:":[338],"NCT03171025.":[339]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":2}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2022-02-24T00:00:00"}